Background: Neuromyelitis optica (NMO) frequently begins with a monofocal episode of optic neuritis or myelitis. A concept named high-risk syndrome (HRS) for NMO has been proposed for patients with monofocal episodes and NMO-IgG antibodies.
Objective: To describe HRS patients and compare them with NMO patients.
Methods: We identified 30 patients with HRS: 18 with extensive myelitis (HRM) and 12 with optic neuritis (HRON), in a database pooling patients from 25 centres in France. Clinical, laboratory/magnetic resonance imaging (MRI) data and outcome were analysed and compared with a national cohort of 125 NMO patients extracted from the same database.
Results: Mean follow-up was 4.8 years. Mean age at onset was 42.8 years (range: 12.4–70) with a female:male ratio of 0.9. Asymptomatic lesions were report on visual evoked potentials in 4/8 tested HRM patients and on spinal cord MRI in 2/7 HRON patients. Three patients died, two owing to a cervical lesion. HRS and NMO patients had similar clinical/paraclinical data, except for a predominance of men in the HRS group and a later mean age at onset in the HRM subgroup.
Conclusion: The description of HRS patients is compatible with a monofocal form of NMO. Asymptomatic lesions could be included in a new set of NMO diagnostic criteria.
WingerchukDMHogancampWFO’BrienPCWeinshenkerBG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology1999; 53: 1107–1114.
2.
WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBG. Revised diagnostic criteria for neuromyelitis optica. Neurology2006; 66: 1485–1489.
3.
LennonVAWingerchukDMKryzerTJ. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet2004; 364: 2106–2112.
4.
CollonguesNMarignierRZephirH. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology2010; 74: 736–742.
5.
MarignierRDe SezeJVukusicS. NMO-IgG and Devic’s neuromyelitis optica: a French experience. Mult Scler2008; 14: 440–445.
6.
NakashimaIFujiharaKMiyazawaI. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry2006; 77: 1073–1075.
7.
WatersPVincentA. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J2008; 15: 99–105.
8.
de SezeJArndtCJeanjeanL. Relapsing inflammatory optic neuritis: is it neuromyelitis optica?Neurology2008; 70: 2075–2076.
9.
MatielloMLennonVAJacobA. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology2008; 70: 2197–2200.
10.
WeinshenkerBGWingerchukDMVukusicS. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol2006; 59: 566–569.
11.
ConfavreuxCCompstonDAHommesORMcDonaldWIThompsonAJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry1992; 55: 671–676.
12.
CabrePGonzalez-QuevedoABonnanM. Relapsing neuromyelitis optica: long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry2009; 80: 1162–1164.
13.
ScottTFKassabSLPittockSJ. Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol2006; 63: 1398–1400.
14.
YanagawaKKawachiIToyoshimaY. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis. Neurology2009; 73: 1628–1637.
